192 related articles for article (PubMed ID: 30170359)
41. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
42. Dynamics of delivering aptamer targeted nano-drugs into cells.
Liu Y; Yang Y; Zhang Q; Lu D; Li S; Li J; Yang G; Shan Y
J Mater Chem B; 2021 Jan; 9(4):952-957. PubMed ID: 33437980
[TBL] [Abstract][Full Text] [Related]
43. Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy.
Ai J; Xu Y; Lou B; Li D; Wang E
Talanta; 2014 Jan; 118():54-60. PubMed ID: 24274270
[TBL] [Abstract][Full Text] [Related]
44. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
45. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
46. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles.
Li X; Yu Y; Ji Q; Qiu L
Nanomedicine; 2015 Jan; 11(1):175-84. PubMed ID: 25218928
[TBL] [Abstract][Full Text] [Related]
47. Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs.
Riccardi C; Musumeci D; Platella C; Gaglione R; Arciello A; Montesarchio D
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183039
[TBL] [Abstract][Full Text] [Related]
48. AS1411-conjugated gold nanospheres and their potential for breast cancer therapy.
Malik MT; O'Toole MG; Casson LK; Thomas SD; Bardi GT; Reyes-Reyes EM; Ng CK; Kang KA; Bates PJ
Oncotarget; 2015 Sep; 6(26):22270-81. PubMed ID: 26045302
[TBL] [Abstract][Full Text] [Related]
49. Thioflavin T as a fluorescence light-up probe for both parallel and antiparallel G-quadruplexes of 29-mer thrombin binding aptamer.
Li Y; Xu S; Wu X; Xu Q; Zhao Y; Lou X; Yang X
Anal Bioanal Chem; 2016 Nov; 408(28):8025-8036. PubMed ID: 27590320
[TBL] [Abstract][Full Text] [Related]
50. Aptamer-based approaches to detect nucleolin in prostate cancer.
Miranda A; Santos T; Carvalho J; Alexandre D; Jardim A; Caneira CF; Vaz V; Pereira B; Godinho R; Brito D; Chu V; Conde JP; Cruz C
Talanta; 2021 May; 226():122037. PubMed ID: 33676639
[TBL] [Abstract][Full Text] [Related]
51. AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice.
Ghahremani F; Kefayat A; Shahbazi-Gahrouei D; Motaghi H; Mehrgardi MA; Haghjooy-Javanmard S
Nanomedicine (Lond); 2018 Oct; 13(20):2563-2578. PubMed ID: 30334677
[TBL] [Abstract][Full Text] [Related]
52. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic applications of AS1411 aptamer, an update review.
Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
[TBL] [Abstract][Full Text] [Related]
54. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
55. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
56. Progress in cancer drug delivery based on AS1411 oriented nanomaterials.
Tong X; Ga L; Ai J; Wang Y
J Nanobiotechnology; 2022 Jan; 20(1):57. PubMed ID: 35101048
[TBL] [Abstract][Full Text] [Related]
57. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of a star-like polymeric micelle modified with AS1411 aptamer for targeted delivery of camptothecin for cancer therapy.
Jabbari A; Yaghoobi E; Azizollahi H; Shojaee S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Int J Pharm; 2022 Jan; 611():121346. PubMed ID: 34871712
[TBL] [Abstract][Full Text] [Related]
59. Increasing the accumulation of aptamer AS1411 and verapamil conjugated silver nanoparticles in tumor cells to enhance the radiosensitivity of glioma.
Zhao J; Li D; Ma J; Yang H; Chen W; Cao Y; Liu P
Nanotechnology; 2021 Apr; 32(14):145102. PubMed ID: 33296880
[TBL] [Abstract][Full Text] [Related]
60. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
